Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143316 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143317 |
| CAS No | NA |
| Mol.F. | C5H10N4O |
| Mol.Wt. | 142.16 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143318 |
| CAS No | NA |
| Mol.F. | C7H14N4O |
| Mol.Wt. | 170.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143319 |
| CAS No | NA |
| Mol.F. | C15H16BrN3O |
| Mol.Wt. | 334.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143320 |
| CAS No | NA |
| Mol.F. | C6H6N2O3 |
| Mol.Wt. | 154,.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143321 |
| CAS No | NA |
| Mol.F. | C8H10N2O4 |
| Mol.Wt. | 198.18 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143322 |
| CAS No | NA |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143323 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143324 |
| CAS No | NA |
| Mol.F. | C8H18N2O5 |
| Mol.Wt. | 222.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143325 |
| CAS No | 67856-67-1 |
| Mol.F. | C12H26N2O5 |
| Mol.Wt. | 278.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143326 |
| CAS No | NA |
| Mol.F. | C10H11ClN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143327 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143328 |
| CAS No | NA |
| Mol.F. | C21H27N3O4 |
| Mol.Wt. | 385.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143329 |
| CAS No | NA |
| Mol.F. | C14H21N3O4 |
| Mol.Wt. | 295.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143330 |
| CAS No | NA |
| Mol.F. | C21H29N3O5 |
| Mol.Wt. | 403.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143331 |
| CAS No | NA |
| Mol.F. | C15H20N4O2 |
| Mol.Wt. | 288.35g/mole |
| INV STATUS | CUSTOM SYNTHESIS |